QTLs in Region (mRatBN7.2)
1600378 | Arunc4 | Aerobic running capacity QTL 4 | | 0.03 | exercise endurance trait (VT:0002332) | maximum distance run on treadmill (CMO:0001406) | 16 | 380245 | 80345693 | Rat |
2312660 | Bw95 | Body weight QTL 95 | | 0.05 | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 16 | 832236 | 59492508 | Rat |
2312663 | Slep9 | Serum leptin concentration QTL 9 | | 0.001 | blood leptin amount (VT:0005667) | serum leptin level (CMO:0000780) | 16 | 832236 | 59492508 | Rat |
2312666 | Insul16 | Insulin level QTL 16 | | 0.01 | blood insulin amount (VT:0001560) | serum insulin level (CMO:0000358) | 16 | 832236 | 59492508 | Rat |
2312669 | Stl23 | Serum triglyceride level QTL 23 | | 0.01 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 16 | 832236 | 59492508 | Rat |
737826 | Alc11 | Alcohol consumption QTL 11 | 3.2 | | consumption behavior trait (VT:0002069) | ethanol drink intake rate (CMO:0001407) | 16 | 4227609 | 60252231 | Rat |
70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | | stomach morphology trait (VT:0000470) | stomach tumor depth of invasion (CMO:0001888) | 16 | 17696791 | 82635055 | Rat |
70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | | stomach morphology trait (VT:0000470) | stomach tumor depth of invasion (CMO:0001888) | 16 | 17696791 | 82635055 | Rat |
70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | | stomach morphology trait (VT:0000470) | stomach tumor diameter (CMO:0001889) | 16 | 17696791 | 82635055 | Rat |
70205 | Gcr3 | Gastric cancer resistance QTL 3 | 2.3 | | stomach morphology trait (VT:0000470) | stomach tumor diameter (CMO:0001889) | 16 | 17696791 | 82635055 | Rat |
70215 | Niddm29 | Non-insulin dependent diabetes mellitus QTL 29 | 3.54 | | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 16 | 19004435 | 75226532 | Rat |
2302057 | Pia29 | Pristane induced arthritis QTL 29 | 3.6 | 0.001 | blood autoantibody amount (VT:0003725) | serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) | 16 | 21735975 | 66735975 | Rat |
8694453 | Bw172 | Body weight QTL 172 | 8.33 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 16 | 24325513 | 69325513 | Rat |
6903294 | Stl30 | Serum triglyceride level QTL 30 | 2.6 | 0.0013 | blood triglyceride amount (VT:0002644) | plasma triglyceride level (CMO:0000548) | 16 | 25152793 | 70152793 | Rat |
1298529 | Arunc1 | Aerobic running capacity QTL 1 | 4 | | exercise endurance trait (VT:0002332) | maximum distance run on treadmill (CMO:0001406) | 16 | 31951520 | 60148445 | Rat |
1578768 | Stresp22 | Stress response QTL 22 | 2.8 | | thymus mass (VT:0004954) | thymus wet weight (CMO:0000855) | 16 | 35288870 | 80288870 | Rat |
2293690 | Bss45 | Bone structure and strength QTL 45 | 5.13 | 0.0001 | lumbar vertebra morphology trait (VT:0010494) | lumbar vertebra cortical cross-sectional area (CMO:0001690) | 16 | 37752156 | 82752156 | Rat |
2300163 | Bmd64 | Bone mineral density QTL 64 | 5.3 | 0.0001 | lumbar vertebra mineral mass (VT:0010511) | volumetric bone mineral density (CMO:0001553) | 16 | 37752156 | 82752156 | Rat |
7205510 | Activ5 | Activity QTL 5 | 3.78 | 0.00028 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 16 | 42396345 | 84729064 | Rat |
8694429 | Bw164 | Body weight QTL 164 | 5 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 16 | 52726464 | 84729064 | Rat |
8694364 | Abfw7 | Abdominal fat weight QTL 7 | 12.22 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 16 | 52726464 | 84729064 | Rat |
7411648 | Foco22 | Food consumption QTL 22 | 15 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 16 | 52726464 | 84729064 | Rat |
631525 | Pia14 | Pristane induced arthritis QTL 14 | 4.4 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 16 | 55711087 | 83402471 | Rat |
7207486 | Bss109 | Bone structure and strength QTL 109 | | | femur strength trait (VT:0010010) | femur total energy absorbed before break (CMO:0001677) | 5 | 106906205 | 151906205 | Rat |
7207491 | Bss112 | Bone structure and strength QTL 112 | 7 | | femur morphology trait (VT:0000559) | femur midshaft cortical cross-sectional area (CMO:0001663) | 5 | 106906205 | 151906205 | Rat |
8694169 | Bw148 | Body weight QTL 148 | 5 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 128506074 | 166875058 | Rat |
1298089 | Scl14 | Serum cholesterol level QTL 14 | 5.8 | 0.0004 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 108845856 | 153845856 | Rat |
1549838 | Bss4 | Bone structure and strength QTL 4 | 9.2 | | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 5 | 106906205 | 151906205 | Rat |
7207481 | Bss106 | Bone structure and strength QTL 106 | 7.9 | | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 106906205 | 151906205 | Rat |
1578766 | Tcas11 | Tongue tumor susceptibility QTL 11 | 4.12 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 5 | 46711509 | 161317411 | Rat |
1302790 | Scl20 | Serum cholesterol level QTL 20 | 6.4 | 0.0001 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 5 | 82394392 | 166664054 | Rat |
1576314 | Eutr1 | Estrogen induced uterine response QTL 1 | | | uterus integrity trait (VT:0010575) | pyometritis severity score (CMO:0002009) | 5 | 2138965 | 166875058 | Rat |
631562 | Apr2 | Acute phase response QTL 2 | 3.7 | | blood murinoglobulin 1 amount (VT:0010597) | plasma murinoglobulin 1 level (CMO:0001931) | 5 | 135927956 | 166875058 | Rat |
1358187 | Emca1 | Estrogen-induced mammary cancer QTL 1 | 4.4 | | mammary gland integrity trait (VT:0010552) | post-insult time to mammary tumor formation (CMO:0000345) | 5 | 99216724 | 148607142 | Rat |
7207488 | Bss110 | Bone structure and strength QTL 1 | 8.4 | | femur strength trait (VT:0010010) | femur stiffness (CMO:0001674) | 5 | 106906205 | 151906205 | Rat |
2293642 | Bss37 | Bone structure and strength QTL 37 | 4.64 | 0.0001 | femur strength trait (VT:0010010) | femur ultimate force (CMO:0001675) | 5 | 120740824 | 151018848 | Rat |
1549845 | Scl44 | Serum cholesterol level QTL 44 | 6 | | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 40128307 | 148607290 | Rat |
2302369 | Scl60 | Serum cholesterol level QTL 60 | 3.13 | | blood cholesterol amount (VT:0000180) | serum total cholesterol level (CMO:0000363) | 5 | 143608201 | 161165651 | Rat |
8694389 | Bw160 | Body weight QTL 160 | 6.17 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 5 | 111416838 | 156416838 | Rat |
8694441 | Bw169 | Body weight QTL 169 | 17.61 | 0.001 | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 5 | 111416838 | 156416838 | Rat |
2317056 | Wbc3 | White blood cell count QTL 3 | 2.51 | 0.01 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 5 | 105999803 | 150999803 | Rat |
10053720 | Scort26 | Serum corticosterone level QTL 26 | 2.06 | 0.0147 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 5 | 124965598 | 166875058 | Rat |
8657050 | Bw146 | Body weight QTL 146 | 19.84 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 5 | 108938288 | 153938288 | Rat |
1578673 | Bmd13 | Bone mineral density QTL 13 | 4.9 | | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 5 | 103689353 | 148689353 | Rat |
8552908 | Pigfal4 | Plasma insulin-like growth factor 1 level QTL 4 | 6.6 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 128506074 | 166875058 | Rat |
61444 | Strs2 | Sensitivity to stroke QTL 2 | 4.7 | | cerebrum integrity trait (VT:0010549) | post-insult time to onset of cerebrovascular lesion (CMO:0002343) | 5 | 135929696 | 166875058 | Rat |
631263 | Cm24 | Cardiac mass QTL 24 | 3.5 | | heart mass (VT:0007028) | heart left ventricle weight to body weight ratio (CMO:0000530) | 5 | 143799107 | 158428037 | Rat |
1641920 | Colcs1 | Colorectal carcinoma susceptibility QTL 1 | 2.99 | 0.0055 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 5 | 121846814 | 166846814 | Rat |
8552960 | Pigfal15 | Plasma insulin-like growth factor 1 level QTL 15 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 5 | 111416838 | 156416838 | Rat |
1300119 | Bp180 | Blood pressure QTL 180 | 3.82 | | arterial blood pressure trait (VT:2000000) | blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) | 5 | 144358090 | 157869054 | Rat |
1331721 | Bp210 | Blood pressure QTL 210 | 3.413 | | arterial blood pressure trait (VT:2000000) | blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) | 5 | 143069996 | 166846814 | Rat |
631505 | Bp103 | Blood pressure QTL 103 | 3.2 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 132717196 | 165560427 | Rat |
61393 | Bp7 | Blood pressure QTL 7 | 4.5 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 60293434 | 161481680 | Rat |
1354598 | Srn6 | Serum renin concentration QTL 6 | 3.8 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 5 | 69540295 | 151018848 | Rat |
634349 | Bp139 | Blood pressure QTL 139 | | 0.001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 128924607 | 166875058 | Rat |
70156 | Niddm30 | Non-insulin dependent diabetes mellitus QTL 30 | 3.98 | | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 5 | 129132447 | 151006154 | Rat |
724525 | Bp147 | Blood pressure QTL 147 | 4.3 | 0.0001 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 126424772 | 166875058 | Rat |
1598819 | Bp292 | Blood pressure QTL 292 | 4.3 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 5 | 127798274 | 166875058 | Rat |
1598847 | Cm62 | Cardiac mass QTL 62 | 3.4 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 108845856 | 153845856 | Rat |
1598861 | Cm64 | Cardiac mass QTL 64 | 2.9 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 5 | 127798274 | 166875058 | Rat |
7794791 | Mcs33 | Mammary carcinoma susceptibility QTL 33 | 1.93 | | mammary gland integrity trait (VT:0010552) | mammary tumor incidence/prevalence measurement (CMO:0000946) | 5 | 131345754 | 166875058 | Rat |
2313096 | Bmd78 | Bone mineral density QTL 78 | 3.1 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 5 | 144377876 | 161317411 | Rat |
738018 | Anxrr4 | Anxiety related response QTL 4 | 5.1 | | exploratory behavior trait (VT:0010471) | percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) | 5 | 130130159 | 166875058 | Rat |
1331796 | Thshl2 | Thyroid stimulating hormone level QTL 2 | 2.3 | | blood thyroid-stimulating hormone amount (VT:0005119) | serum thyroid stimulating hormone level (CMO:0001248) | 5 | 97059760 | 147465714 | Rat |
8694198 | Abfw3 | Abdominal fat weight QTL 3 | 16.13 | 0.001 | visceral adipose mass (VT:0010063) | abdominal fat pad weight to body weight ratio (CMO:0000095) | 5 | 111416838 | 156416838 | Rat |
1554320 | Bmd1 | Bone mineral density QTL 1 | 12.2 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 1 | 509108 | 86060548 | Rat |
631688 | Hcas2 | Hepatocarcinoma susceptibility QTL 2 | 3 | 0.0001 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 1 | 5925874 | 115540829 | Rat |
1300167 | Hrtrt2 | Heart rate QTL 2 | 4.35 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 11481312 | 75088344 | Rat |
2313062 | Bmd73 | Bone mineral density QTL 73 | 3.9 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 11481312 | 82174945 | Rat |
2313065 | Bss67 | Bone structure and strength QTL 67 | 3.1 | 0.0001 | tibia area (VT:1000281) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
2313069 | Bss68 | Bone structure and strength QTL 68 | 2.9 | 0.0001 | tibia size trait (VT:0100001) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
2313075 | Bss66 | Bone structure and strength QTL 66 | 3.4 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 11481312 | 82174945 | Rat |
2313077 | Bss69 | Bone structure and strength QTL 69 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 11481312 | 82174945 | Rat |
2313092 | Bmd72 | Bone mineral density QTL 72 | 2.5 | 0.0001 | tibia mineral mass (VT:1000283) | total volumetric bone mineral density (CMO:0001728) | 1 | 11481312 | 82174945 | Rat |
2313097 | Bss70 | Bone structure and strength QTL 70 | 3.5 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 11481312 | 82174945 | Rat |
1357400 | Bw62 | Body weight QTL62 | 4.05 | | inguinal fat pad mass (VT:0010424) | inguinal fat pad weight to body weight ratio (CMO:0001253) | 1 | 22340647 | 67340647 | Rat |
631495 | Bp96 | Blood pressure QTL 96 | 4.52 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 22340647 | 102268831 | Rat |
1331785 | Rf27 | Renal function QTL 27 | 4.643 | | urine sodium amount (VT:0006274) | urine sodium level (CMO:0000129) | 1 | 28879780 | 78430678 | Rat |
1358359 | Sradr1 | Stress Responsive Adrenal Weight QTL 1 | 4.74 | | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 1 | 30882023 | 123479925 | Rat |
70225 | Bp58 | Blood pressure QTL 58 | 3.3 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32356093 | 162846471 | Rat |
1300172 | Bp172 | Blood pressure QTL 172 | 3.56 | | arterial blood pressure trait (VT:2000000) | diastolic blood pressure (CMO:0000005) | 1 | 32737273 | 90665040 | Rat |
10059597 | Bp377 | Blood pressure QTL 377 | 3.42 | 0.025 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 32737458 | 199368955 | Rat |
1354599 | Bw29 | Body weight QTL 29 | 3.46 | 0.001 | body mass (VT:0001259) | body weight (CMO:0000012) | 1 | 33449848 | 78449848 | Rat |
1354643 | Foco2 | Food consumption QTL 2 | 7.17 | 0.0001 | eating behavior trait (VT:0001431) | food intake rate (CMO:0000427) | 1 | 33449848 | 78449848 | Rat |
8552900 | Pigfal1 | Plasma insulin-like growth factor 1 level QTL 1 | 7.4 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat |
8552948 | Pigfal11 | Plasma insulin-like growth factor 1 level QTL 11 | 4.7 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 1 | 34836858 | 79836858 | Rat |
9589820 | Insglur3 | Insulin/glucose ratio QTL 3 | 10.75 | 0.001 | blood insulin amount (VT:0001560) | calculated plasma insulin level (CMO:0002170) | 1 | 34836858 | 79836858 | Rat |
1331732 | Srn4 | Serum renin concentration QTL 4 | 4.467 | | renin activity (VT:0005581) | plasma renin activity level (CMO:0000116) | 1 | 35239598 | 78430678 | Rat |
1331792 | Rf29 | Renal function QTL 29 | 4.589 | | urine potassium amount (VT:0010539) | urine potassium level (CMO:0000128) | 1 | 35239598 | 78430678 | Rat |
2313051 | Bss57 | Bone structure and strength QTL 57 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | bone polar moment of inertia (CMO:0001558) | 1 | 43284731 | 118944897 | Rat |
2313059 | Bss55 | Bone structure and strength QTL 55 | 3.2 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat |
2313072 | Bss53 | Bone structure and strength QTL 53 | 4.3 | 0.0001 | tibia length (VT:0004357) | tibia length (CMO:0000450) | 1 | 43284731 | 118944897 | Rat |
2313078 | Bss54 | Bone structure and strength QTL 54 | 3.5 | 0.0001 | tibia area (VT:1000281) | tibia midshaft cross-sectional area (CMO:0001717) | 1 | 43284731 | 118944897 | Rat |
2313094 | Bss58 | Bone structure and strength QTL 58 | 3.7 | 0.0001 | tibia strength trait (VT:1000284) | tibia total energy absorbed before break (CMO:0001736) | 1 | 43284731 | 118944897 | Rat |
2313098 | Bmd70 | Bone mineral density QTL 70 | 3.6 | 0.0001 | tibia mineral mass (VT:1000283) | compact volumetric bone mineral density (CMO:0001730) | 1 | 43284731 | 118944897 | Rat |
2313099 | Bss56 | Bone structure and strength QTL 56 | 2.4 | 0.0001 | tibia size trait (VT:0100001) | tibia midshaft endosteal cross-sectional area (CMO:0001716) | 1 | 43284731 | 118944897 | Rat |
2302059 | Pia36 | Pristane induced arthritis QTL 36 | 3.8 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G1 level (CMO:0002115) | 1 | 43333002 | 88333002 | Rat |
1331778 | Rf28 | Renal function QTL 28 | 4.66 | | urine potassium amount (VT:0010539) | urine potassium excretion rate (CMO:0000761) | 1 | 45803140 | 78430678 | Rat |
2313402 | Anxrr24 | Anxiety related response QTL 24 | | | aggression-related behavior trait (VT:0015014) | tameness/aggressiveness composite score (CMO:0002136) | 1 | 48963584 | 144267916 | Rat |
4889962 | Bss94 | Bone structure and strength QTL 94 | 3.8 | | tibia area (VT:1000281) | tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) | 1 | 49361465 | 82174945 | Rat |
1578649 | Bmd8 | Bone mineral density QTL 8 | 4.9 | | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 1 | 49393172 | 94393172 | Rat |
1578654 | Bss10 | Bone structure and strength QTL 10 | 4 | | femur morphology trait (VT:0000559) | femoral neck cortical cross-sectional area (CMO:0001702) | 1 | 49393172 | 159356837 | Rat |
634314 | Niddm44 | Non-insulin dependent diabetes mellitus QTL 44 | | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 1 | 49393289 | 199050459 | Rat |
6903308 | Scl36 | Serum cholesterol QTL 36 | 2 | 0.0125 | blood cholesterol amount (VT:0000180) | plasma total cholesterol level (CMO:0000585) | 1 | 53863041 | 90532583 | Rat |
4889919 | Bss86 | Bone structure and strength QTL 86 | 4.1 | | tibia area (VT:1000281) | tibia midshaft total cross-sectional area (CMO:0001715) | 1 | 53895117 | 82174945 | Rat |
4889929 | Bss87 | Bone structure and strength QTL 87 | 6.7 | | tibia area (VT:1000281) | tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722) | 1 | 53895117 | 82174945 | Rat |
61342 | Bp27 | Blood pressure QTL 27 | 3.4 | 0.0006 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 1 | 56732668 | 98773277 | Rat |
2300164 | Bmd44 | Bone mineral density QTL 44 | 5.4 | 0.0001 | lumbar vertebra mineral mass (VT:0010511) | volumetric bone mineral density (CMO:0001553) | 1 | 56949932 | 101949932 | Rat |
2298545 | Neuinf8 | Neuroinflammation QTL 8 | 4.6 | | nervous system integrity trait (VT:0010566) | spinal cord beta-2 microglobulin mRNA level (CMO:0002125) | 1 | 57336763 | 151090257 | Rat |
1300121 | Hrtrt1 | Heart rate QTL 1 | 3.7 | | heart pumping trait (VT:2000009) | heart rate (CMO:0000002) | 1 | 65789093 | 115540829 | Rat |
7421628 | Bp361 | Blood pressure QTL 361 | | 0.001 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 1 | 66023617 | 118608521 | Rat |
70226 | Eae4 | Experimental allergic encephalomyelitis QTL 4 | | | nervous system integrity trait (VT:0010566) | experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) | 9 | 1 | 25661317 | Rat |
9589055 | Scfw5 | Subcutaneous fat weight QTL 5 | 5.55 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 9 | 1 | 37999212 | Rat |
7411592 | Foco8 | Food consumption QTL 8 | 7.4 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 9 | 1 | 37999212 | Rat |
9589158 | Gluco65 | Glucose level QTL 65 | 6.82 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 9 | 1 | 37999212 | Rat |
1300124 | Cm4 | Cardiac mass QTL 4 | 3.55 | | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 9 | 1 | 40594091 | Rat |
1298088 | Edpm11 | Estrogen-dependent pituitary mass QTL 11 | 2.5 | | pituitary gland mass (VT:0010496) | pituitary gland wet weight (CMO:0000853) | 9 | 1 | 43718459 | Rat |
1641911 | Alcrsp13 | Alcohol response QTL 13 | | | response to alcohol trait (VT:0010489) | brain neurotensin receptor 1 density (CMO:0002068) | 9 | 1 | 43718459 | Rat |
10054125 | Srcrt7 | Stress Responsive Cort QTL 7 | 3.33 | 0.0011 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 9 | 1 | 87073594 | Rat |
1331757 | Cdexp1 | CD45RC expression in CD8 T cells QTL 1 | 4.3 | | CD8-positive T cell quantity (VT:0008077) | blood CD45RC(high) CD8 T cell count to CD45RC(low) CD8 T cell count ratio (CMO:0001990) | 9 | 1024537 | 67509080 | Rat |
1354650 | Despr5 | Despair related QTL 5 | 4.01 | 0.0017 | locomotor behavior trait (VT:0001392) | amount of time spent in voluntary immobility (CMO:0001043) | 9 | 1254084 | 46254084 | Rat |
2303559 | Gluco54 | Glucose level QTL 54 | 2 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 9 | 1254084 | 46254084 | Rat |
61425 | Cia15 | Collagen induced arthritis QTL 15 | 4.6 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 9 | 5109826 | 42921101 | Rat |
631211 | Bw4 | Body weight QTL4 | 5.31 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 9 | 5109826 | 50109826 | Rat |
11353947 | Bp392 | Blood pressure QTL 392 | | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 9 | 7283252 | 52283252 | Rat |
61450 | Ciaa3 | CIA Autoantibody QTL 3 | 6.5 | | blood autoantibody amount (VT:0003725) | calculated serum anti-type 2 collagen antibody titer (CMO:0001279) | 9 | 7954720 | 22071169 | Rat |
9589133 | Insul26 | Insulin level QTL 26 | 17.96 | 0.001 | blood insulin amount (VT:0001560) | plasma insulin level (CMO:0000342) | 9 | 8952560 | 53952560 | Rat |
7411609 | Foco16 | Food consumption QTL 16 | 25.6 | 0.001 | eating behavior trait (VT:0001431) | feed conversion ratio (CMO:0001312) | 9 | 8952560 | 53952560 | Rat |
1600365 | Mcs20 | Mammary carcinoma susceptibility QTL 20 | 3 | | mammary gland integrity trait (VT:0010552) | mammary tumor growth rate (CMO:0000344) | 9 | 13533770 | 42791750 | Rat |
724543 | Cm20 | Cardiac mass QTL 20 | 3.9 | | heart mass (VT:0007028) | calculated heart weight (CMO:0000073) | 9 | 16961398 | 40594091 | Rat |